Document is current
Any future updates will be listed below
-
Authors
Luan, Chunyan
Wessely, Anja
Zhang, Zhesi
Zhang, Liang
Weich, Adrian
Lischer, Christopher
Berking, Carola
Heppt, Markus V.
Vera, Julio
-
Funding
Funding for this research was provided by:
Tampere University
- License Information
-
More Information
Article History
Received: 23 December 2025
Revised: 27 March 2026
Accepted: 26 April 2026
First Online: 13 May 2026
Declarations
:
: CB reports consulting fees from BMS, Almirall Hermal, Immunocore, MSD, Novartis, Regeneron, Sanofi, Pierre Fabre; honoraria for lectures from Bristol Myers Squibb (BMS), Merck Sharpe and Dohme (MSD), Almirall Hermal, Immunocore, Novartis, Sanofi, Pierre Fabre, Leo Pharma; support for attending meetings from Pierre Fabre; participation on advisory boards of InflaRx, Miltenyi, BMS, Almirall Hermal, Immunocore, MSD, Novartis, Regeneron, Sanofi, Pierre Fabre outside the submitted work. CB is a board member of the Dermatologic Cooperative Oncology group (DeCOG). MH received honoraria for lectures and presentations from Novartis, BMS, MSD, and Immunocore and participated on data safety monitoring boards or advisory boards of Novartis, BMS, MSD, and Immunocore. The other authors declare no conflict of interest.
